NHS has ‘culture of cover-up' over failures, Health Secretary says
He told MPs there is 'too much of that happening' in the NHS, and that reputations are protected instead of patients being told the truth.
The minister's comments came after Labour MP Perran Moon (Camborne and Redruth) told him about the experience of a woman in his constituency who suffered from nerve damage after a hip operation, but was told her pain was 'common'.
Mr Moon said: 'A couple of weeks ago at my constituency surgery, through the tears, my constituent Amy explained how, following a hip operation in 2008, she suffered progressive nerve damage due to repeated failures in diagnosis, referral and treatment.
'Despite raising concerns for years, she was told her pain was common.
'A nerve test in 2015 confirmed damage and further tests last year showed a significant deterioration. After 17 years, she's only now been offered surgery.
'All Amy wants to know is what steps are being taken to ensure that no other patient is left permanently disabled due to such long and systemic failures.'
Responding, Mr Streeting said: 'Can I first of all, on behalf of the NHS, apologise to his constituent.
'That is a totally intolerable situation, but sadly not rare or exceptional.
'There's too much of that happening and a culture of cover-up and covering reputations, rather than being honest with patients about failures.
'We are changing the culture, safety is at the heart of the 10-year plan, and I'd be delighted to talk to him further about his constituent's case.'
Elsewhere during health and social care oral questions on Tuesday, the Government was challenged on the difficulties that pharmacies are facing.
Liberal Democrat MP Caroline Voaden (South Devon) told MPs the 'current funding model doesn't take into account the lower footfall and the limited referral rates that are common in rural areas'.
She said: 'If a pharmacy in a small market town closes, it can cause extreme difficulties for people to access advice and medicines, particularly where there is little or no public transport and they have to go a long way.'
Conservative shadow health minister Dr Luke Evans raised the cap on funded consultation appointments that pharmacies can schedule through the Pharmacy First Scheme.
He said: 'Once they hit that cap, they are no longer paid the £17 per consultation.
'That, in turn, may mean patients will either be turned away or the pharmacist has to take the hit and has to pay for it themselves.'
Care minister Stephen Kinnock replied: 'The pharmacy sector is facing huge challenges after massive cuts over the last 14 years. We're beginning to rebuild, but there are particular challenges for rural pharmacies.
'We are looking at comprehensive reform in the pharmacy sector around better use of technology, hub-and-spoke dispensing and a range of other options which would enable better remote dispensing for rural pharmacies.'
He told Dr Evans that the 'record uplift' of £3.1 billion for the pharmacy sector was coming in 'after years of underfunding, incompetence and neglect' from the Conservatives, and that the allocation of funding will be looked at in their reforms.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South Wales Guardian
2 hours ago
- South Wales Guardian
UK economic growth downgraded due to tariffs and cost hikes
Rising costs are set to cause 'weak' business investment and weigh on the Government's ambitions to accelerate growth in the UK economy, the Confederation of British Industry (CBI) said. The influential trade body's latest economic forecast indicated that the UK economy is on track to grow by 1.2% this year. It had previously predicted a rise of 1.6%. It also downgraded its growth forecast for 2026 from 1.5% to 1% for the year. The CBI highlighted that the UK has seen strong growth over the start of the year, rising by 0.7% in the first three months of 2025. But it suggested underlying activity 'remains sluggish' due to persistently weak demand and gloomy sentiment among businesses. It added that higher employment costs linked to the autumn budget, including rises to national insurance contributions and the increased national minimum wage, have impacted firms. It said this has fed into higher pricing and reduced capital expenditure and hiring among many firms. Meanwhile, higher US tariffs from President Trump's administration have also created headwinds for exports to the US and hindered investment from multinational companies in the UK. It comes after Donald Trump and the Prime Minister finalised a US-UK deal intended to slash trade barriers on goods from both countries while at the G7 summit in Canada earlier this week. Louise Hellem, chief economist at the CBI, said: 'Our latest economic forecast underlines the challenges facing businesses and the wider economy as they're buffeted by domestic and global headwinds. 'The unpredictable global outlook combined with rising employment costs, gloomy business sentiment, and subdued investment intentions means it's more important than ever that government pulls all the levers it can to set the UK on a path to sustainable growth. 'With GDP (gross domestic product) set to remain modest in 2026, there is an important opportunity for the government to fire up the growth agenda in the forthcoming Industrial Strategy. 'With the cumulative burden of increased costs being felt by firms across the economy, it is vital the Industrial Strategy helps drive a thriving environment for all businesses.'
South Wales Guardian
2 hours ago
- South Wales Guardian
NHS launches new drive to find more people with deadly pancreatic cancer
Hundreds of GP practices in England are being given extra funding to comb patient records looking for people with the disease, which has the lowest survival rate of all cancers. GPs and their teams will look for people over 60 who may have signs of the cancer, such as a recent diagnosis of diabetes and sudden weight loss. Figure suggest that around half of people diagnosed with pancreatic cancer have been diagnosed with type 1 or 2 diabetes recently. Family doctors taking part in the NHS England pilot will then contact patients and send them for urgent blood tests and CT scans to rule cancer in or out. Pancreatic cancer can have vague symptoms and is often diagnosed in the late stages. According to researchers, newly-diagnosed diabetes patients often have similar symptoms as a person with early-stage pancreatic cancer. This is because the cancer destroys the same insulin-producing cells that are also destroyed in diabetes. Around 10,500 people in the UK are diagnosed with pancreatic cancer every year and only around one in 20 survive the disease for 10 years or more. More than half of people die within three months of diagnosis. For the new three-year pilot, more than 300 GP practices in England will be involved, with all practices up and running by the autumn. Almost £2 million in targeted funding has been invested to help practices find people most at risk and give patients the best chance of being diagnosed early. Professor Peter Johnson, NHS national clinical director for cancer, said: 'Pancreatic cancer is responsible for so many deaths because patients don't usually notice symptoms until the cancer is at an advanced stage, which is why we need to find new ways to pick it up. 'Through initiatives like this and the upcoming 10-year health plan, the NHS is determined to go a step further – not just treat people at an advanced stage but to go out into communities and seek people out who might be unwell without any symptoms so we can provide people with the most effective treatment. 'The NHS is seeing and treating more people with cancer than ever, and early diagnosis is key to ensure patients have the best chance of receiving effective treatment. 'If your GP practice identifies you as at risk of pancreatic cancer, I urge you to come forward for testing as soon as possible.' Health minister Karin Smyth said: 'This targeted approach to identify people at risk of one of the most lethal cancers could give more people a fighting chance and spare the heartbreak of countless families.' We're delighted to see the Government commit to boosting clinical trials as part of their forthcoming 10 year plan. Clinical trials are a crucial treatment option for people with #PancreaticCancer & improving access to them could be key to driving up treatment & survival rates 🧪 — Pancreatic Cancer UK (@PancreaticCanUK) June 16, 2025 Alfie Bailey-Bearfield, head of influencing and health improvement at Pancreatic Cancer UK, said: 'Diagnosing more people with pancreatic cancer earlier, when the disease is most treatable, would make the single biggest difference to improving survival, so we are delighted to see significant further investment from NHS England towards that incredibly important goal. 'We're proud to have been involved in shaping this new case finding pilot, which will support GPs to proactively find people with pancreatic cancer among one of largest groups known to be at increased risk: those aged over 60, with new onset diabetes who have recently lost weight without trying to do so. 'Many of the people who are referred for a CT scan during the pilot will not have pancreatic cancer, but for those that do, the impact could be lifesaving. 'Subject to the pilot's success, we will be calling for this pilot to be expanded across the country to help give more people affected by the deadliest common cancer the very best chance of survival.' Previous research has shown that people over 50 with a new case of type 2 diabetes have a higher chance of being diagnosed with pancreatic cancer within three years.
North Wales Chronicle
2 hours ago
- North Wales Chronicle
NHS launches new drive to find more people with deadly pancreatic cancer
Hundreds of GP practices in England are being given extra funding to comb patient records looking for people with the disease, which has the lowest survival rate of all cancers. GPs and their teams will look for people over 60 who may have signs of the cancer, such as a recent diagnosis of diabetes and sudden weight loss. Figure suggest that around half of people diagnosed with pancreatic cancer have been diagnosed with type 1 or 2 diabetes recently. Family doctors taking part in the NHS England pilot will then contact patients and send them for urgent blood tests and CT scans to rule cancer in or out. Pancreatic cancer can have vague symptoms and is often diagnosed in the late stages. According to researchers, newly-diagnosed diabetes patients often have similar symptoms as a person with early-stage pancreatic cancer. This is because the cancer destroys the same insulin-producing cells that are also destroyed in diabetes. Around 10,500 people in the UK are diagnosed with pancreatic cancer every year and only around one in 20 survive the disease for 10 years or more. More than half of people die within three months of diagnosis. For the new three-year pilot, more than 300 GP practices in England will be involved, with all practices up and running by the autumn. Almost £2 million in targeted funding has been invested to help practices find people most at risk and give patients the best chance of being diagnosed early. Professor Peter Johnson, NHS national clinical director for cancer, said: 'Pancreatic cancer is responsible for so many deaths because patients don't usually notice symptoms until the cancer is at an advanced stage, which is why we need to find new ways to pick it up. 'Through initiatives like this and the upcoming 10-year health plan, the NHS is determined to go a step further – not just treat people at an advanced stage but to go out into communities and seek people out who might be unwell without any symptoms so we can provide people with the most effective treatment. 'The NHS is seeing and treating more people with cancer than ever, and early diagnosis is key to ensure patients have the best chance of receiving effective treatment. 'If your GP practice identifies you as at risk of pancreatic cancer, I urge you to come forward for testing as soon as possible.' Health minister Karin Smyth said: 'This targeted approach to identify people at risk of one of the most lethal cancers could give more people a fighting chance and spare the heartbreak of countless families.' We're delighted to see the Government commit to boosting clinical trials as part of their forthcoming 10 year plan. Clinical trials are a crucial treatment option for people with #PancreaticCancer & improving access to them could be key to driving up treatment & survival rates 🧪 — Pancreatic Cancer UK (@PancreaticCanUK) June 16, 2025 Alfie Bailey-Bearfield, head of influencing and health improvement at Pancreatic Cancer UK, said: 'Diagnosing more people with pancreatic cancer earlier, when the disease is most treatable, would make the single biggest difference to improving survival, so we are delighted to see significant further investment from NHS England towards that incredibly important goal. 'We're proud to have been involved in shaping this new case finding pilot, which will support GPs to proactively find people with pancreatic cancer among one of largest groups known to be at increased risk: those aged over 60, with new onset diabetes who have recently lost weight without trying to do so. 'Many of the people who are referred for a CT scan during the pilot will not have pancreatic cancer, but for those that do, the impact could be lifesaving. 'Subject to the pilot's success, we will be calling for this pilot to be expanded across the country to help give more people affected by the deadliest common cancer the very best chance of survival.' Previous research has shown that people over 50 with a new case of type 2 diabetes have a higher chance of being diagnosed with pancreatic cancer within three years.
